4th Quarter - Amendment

C2 GROUP, LLC for BIOTECHNOLOGY INDUSTRY ORGANIZATION

Firm
Client
Income
$75,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 20, 2011 $75,000 Replaced
4th Quarter - Report Apr 8, 2011 $75,000 Replaced
4th Quarter - Amendment (this page) Apr 8, 2011 $75,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Therapeutic discovery tax credits (H.R. 3962, S. 1796); H.R. 3590; counter measure and orphan drug exemption from pharmaceutical excise tax; Implementation of Section 48D if the IRC, Implementation of Therapeutic Discovery Research Tax Credit.;H.R.5297, Small Business Jobs and Credit Act 2010; H.R.4213/S.3793 Tax Extenders Act of 2009; Small business capital gains incentives for biotech companies;AMT credits in lieu of bonus depreciation for biotech companies. H.R.4853, Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010.

LobbyistCovered position, as disclosed
JOHN CLINE —
THOMAS CRAWFORD —
LESLEY ELLIOTT —
MICHAEL HANSON —
ROLAND NELSON LITTERST —
JEFFERIES MURRAY —
DAVID PATRICK ROBERTSON Leg. Aide & Leg. Correspondent, Sen. Rockefeller

Contacted: SENATE; Treasury, Dept of; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3962 (111th), H.R. 3590 (111th), S. 3793 (111th), H.R. 4213 (111th), S. 1796 (111th), H.R. 4853 (111th), H.R. 5297 (111th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.